Qlucore AB engages in the provision on information technology systems and solutions. The company is headquartered in Lund, Skane and currently employs 20 full-time employees. The company went IPO on 2021-11-05. The Company’s scope of activity revolves around developing Artificial-Intelligence-based (AI-based) software dedicated to the healthcare sector. The software’s aim is to establish a platform improving cancer care in terms of treatment strategies, and more, as well as other therapy areas. What is more, the Firm develops software which is committed to data analysis in relation to medical research. The Company’s software relies on AI-based machine learning and functions by transforming data sets into explanatory visualizations. Additionally, the Firm runs three software products: Qlucore Omics Explorer, Qlucore Diagnostics, as well as Qlucore Insights.
QLUCF stock price ended at $0 on 日曜日, after dropping NaN%
On the latest trading day Jan 18, 2026, the stock price of QLUCF fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for QLUCF decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.